Studies have shown that in glioma cells, activation of the KEAP1-NRF2 signaling axis upregulates SLC7A11 and promotes glutamate secretion, thereby affecting the tumor microenvironment and promoting cell proliferation and resistance to ferroptosis (Fan et al., 2017). Here, NFE2L2 is linked to neoplasm.